Advertisement

Assessment of Surgical Margins

  • Ziv Gil
  • Shorook Na’ara
Chapter
  • 132 Downloads
Part of the Textbooks in Contemporary Dentistry book series (TECD)

Abstract

In oral cavity SCCs, tumor margin status is an important prognostic factor. Achieving negative margins depends primarily on the surgeon skills and the accuracy of intraoperative margin assessment. Tumor margin of less than 5 mm is considered as close margin, while ≥5 mm is defined as negative margin. In patients with early-stage SCC of the oral cavity, close margins were associated with over twofold increase in the risk of recurrence, compared with negative margins. Patients with positive/close margins are amenable to adjuvant radiation or chemoradiation therapy. The utility of specimen-driven margin analysis is associated with a higher rate of negative margins than the traditional patient-driven margin analysis. Specimen-driven margin analysis can prevent escalation of adjuvant treatment in up to 30% of the patients.

References

  1. 1.
    Shah JP, Gil Z. Current concepts in management of oral cancer–surgery. Oral Oncol. England. 2009;45(4–5):394–401.CrossRefGoogle Scholar
  2. 2.
    Alicandri-Ciufelli M, Bonali M, Piccinini A, Marra L, Ghidini A, Cunsolo EM, et al. Surgical margins in head and neck squamous cell carcinoma: what is “close”. Eur Arch Otorhinolaryngol. Germany. 2013;270(10):2603–9.CrossRefGoogle Scholar
  3. 3.
    Fridman E, Na’ara S, Agarwal J, Amit M, Bachar G, Villaret AB, et al. The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: an international collaborative study. Cancer. United States. 2018;124(14):2948–55.Google Scholar
  4. 4.
    Amit M, Yen T-C, Liao C-T, Chaturvedi P, Agarwal JP, Kowalski LP, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study. Cancer. United States. 2013;119(24):4242–8.Google Scholar
  5. 5.
    Amit M, Na’ara S, Leider-Trejo L, Akrish S, Cohen JT, Billan S, et al. Improving the rate of negative margins after surgery for oral cavity squamous cell carcinoma: a prospective randomized controlled study. Head Neck. United States. 2016;38(Suppl 1):E1803–9.CrossRefGoogle Scholar
  6. 6.
    Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. Denmark. 2003;32(1):30–4.CrossRefGoogle Scholar
  7. 7.
    McMahon J, O’Brien CJ, Pathak I, Hamill R, McNeil E, Hammersley N, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. Scotland. 2003;41(4):224–31.CrossRefGoogle Scholar
  8. 8.
    Zelefsky MJ, Harrison LB, Fass DE, Armstrong JG, Shah JP, Strong EW. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys. United States. 1993;25(1):17–21.CrossRefGoogle Scholar
  9. 9.
    Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, et al. A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue. JAMA Otolaryngol Head Neck Surg. United States. 2017;143(6):555–60.CrossRefGoogle Scholar
  10. 10.
    Buchakjian MR, Ginader T, Tasche KK, Pagedar NA, Smith BJ, Sperry SM. Independent predictors of prognosis based on oral cavity squamous cell carcinoma surgical margins. Otolaryngol Head Neck Surg. England. 2018;159:675–82.  https://doi.org/10.1177/0194599818773070.CrossRefGoogle Scholar
  11. 11.
    Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck. United States. 2005;27(11):952–8.CrossRefGoogle Scholar
  12. 12.
    Black C, Marotti J, Zarovnaya E, Paydarfar J. Critical evaluation of frozen section margins in head and neck cancer resections. Cancer. United States. 2006;107(12):2792–800.Google Scholar
  13. 13.
    DiNardo LJ, Lin J, Karageorge LS, Powers CN. Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery. Laryngoscope. United States. 2000;110(10 Pt 1):1773–6.CrossRefGoogle Scholar
  14. 14.
    Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. United States. 2003;349(22):2091–8.CrossRefGoogle Scholar
  15. 15.
    Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. United States. 1991;324(24):1685–90.CrossRefGoogle Scholar
  16. 16.
    Ettl T, El-Gindi A, Hautmann M, Gosau M, Weber F, Rohrmeier C, et al. Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck. Oral Oncol. England. 2016;55:17–23.CrossRefGoogle Scholar
  17. 17.
    Buchakjian MR, Tasche KK, Robinson RA, Pagedar NA, Sperry SM. Association of main specimen and tumor bed margin status with local recurrence and survival in oral cancer surgery. JAMA Otolaryngol Head Neck Surg. United States. 2016;142(12):1191–8.CrossRefGoogle Scholar
  18. 18.
    Gokavarapu S, Rao LMC, Mahajan M, Parvataneni N, Raju KVVN, Chander R. Revision of margins under frozen section in oral cancer: a retrospective study of involved margins in pT1 and pT2 oral cancers. Br J Oral Maxillofac Surg. Scotland. 2015;53(9):875–9.CrossRefGoogle Scholar
  19. 19.
    Chang AMV, Kim SW, Duvvuri U, Johnson JT, Myers EN, Ferris RL, et al. Early squamous cell carcinoma of the oral tongue: comparing margins obtained from the glossectomy specimen to margins from the tumor bed. Oral Oncol. England. 2013;49(11):1077–82.CrossRefGoogle Scholar
  20. 20.
    Gokavarapu S, Chandrasekhara Rao LM, Patnaik SC, Parvataneni N, Raju KVVN, Chander R. Prognostic value of frozen section in t1, t2 carcinoma of oral cavity. Indian J Otolaryngol Head Neck Surg. India. 2015;67(Suppl 1):86–90.CrossRefGoogle Scholar
  21. 21.
    Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. United States. 1993;53(19):4477–80.Google Scholar
  22. 22.
    Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med. United States. 1995;332(7):429–35.CrossRefGoogle Scholar
  23. 23.
    Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg. United States. 2004;130(1):39–44.CrossRefGoogle Scholar
  24. 24.
    Gil Z, Kelly KJ, Brader P, Shah JP, Fong Y, Wong RJ. Utility of a herpes oncolytic virus for the detection of neural invasion by cancer. Neoplasia. United States. 2008;10(4):347–53.CrossRefGoogle Scholar
  25. 25.
    Rosenthal EL, Warram JM, Bland KI, Zinn KR. The status of contemporary image-guided modalities in oncologic surgery. Ann Surg. United States. 2015;261(1):46–55.CrossRefGoogle Scholar
  26. 26.
    Wilke LG, Brown JQ, Bydlon TM, Kennedy SA, Richards LM, Junker MK, et al. Rapid noninvasive optical imaging of tissue composition in breast tumor margins. Am J Surg. United States. 2009;198(4):566–74.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Ziv Gil
    • 1
  • Shorook Na’ara
    • 1
  1. 1.Otolaryngology, Head and Neck Surgery, The Head and Neck CenterRambam Healthcare CampusHaifaIsrael

Personalised recommendations